151P Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non–small cell lung cancer (NSCLC) treated with trastuzumab deruxtecan (T-DXd)

151P Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non–small cell lung cancer (NSCLC) treated with trastuzumab deruxtecan (T-DXd)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 34; pp. S241 - S242
Main Authors: Smit, E.F., Felip, E., Uprety, D., Nagasaka, M., Nakagawa, K., Paz-Ares, L., Pacheco, J., Li, B.T., Planchard, D., Baik, C.S., Goto, Y., Murakami, H., Pereira, K.M.C., Taguchi, A., Kogo, M., Kuwahara, Y., Zou, M., Feng, W., Tsuchihashi, Z., Jänne, P.A.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2023.09.2875